Viread for Chronic hepatitis B
Quick answer: Viread is used for Chronic hepatitis B as part of a nucleotide reverse transcriptase inhibitor (ntrti) treatment regimen. Tenofovir disoproxil fumarate inhibits HIV reverse transcriptase and HBV polymerase via competitive incorporation as a chain terminator The specific dosing for Chronic hepatitis B is determined by your prescriber based on individual factors.
Why is Viread used for Chronic hepatitis B?
Viread belongs to the Nucleotide reverse transcriptase inhibitor (NtRTI) class. Tenofovir disoproxil fumarate inhibits HIV reverse transcriptase and HBV polymerase via competitive incorporation as a chain terminator This action makes it useful for treating or managing Chronic hepatitis B in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Viread is the right choice for a specific patient depends on the type and severity of Chronic hepatitis B, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Chronic hepatitis B
Common adult dosing range: 300 mg once daily. The actual dose for Chronic hepatitis B depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Viread medicine page.
What to expect
Viread treatment for Chronic hepatitis B typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Chronic hepatitis B
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Viread is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Nucleotide reverse transcriptase inhibitor (NtRTI) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Viread
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Viread full prescribing information · All Nucleotide reverse transcriptase inhibitor (NtRTI) alternatives
Frequently asked questions
How effective is Viread for Chronic hepatitis B?
Effectiveness varies by individual response, dose, and severity. Viread is one of several treatment options for Chronic hepatitis B, supported by clinical evidence within the nucleotide reverse transcriptase inhibitor (ntrti) class. Discuss expected response with your prescriber.
How long do I need to take Viread for Chronic hepatitis B?
Treatment duration depends on the nature of Chronic hepatitis B — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Viread when used for Chronic hepatitis B?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Viread for Chronic hepatitis B?
Yes. Multiple medicines and non-drug options exist for Chronic hepatitis B. Alternatives within the nucleotide reverse transcriptase inhibitor (ntrti) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.